Form D Explorer

Form D — Auron Therapeutics, Inc.

0001746139-26-000002 · filed Aug 13, 2026

Offering

Industry: Biotechnology
Exemptions: 06b
Total offering: $12,000,000
Total sold: $7,118,141
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: Auron Therapeutics, Inc.
CIK: 1746139
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: —
Address: 1 Grove Street
Wellesley, MA 02482-9998
Phone: 310-922-5881

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Katharine Yen · Executive Officer

Wellesley, MA Find on LinkedIn ↗
Alexandra Cantley · Director

Wellesley, MA Find on LinkedIn ↗
Briggs Duncan Morrison · Director

Wellesley, MA Find on LinkedIn ↗
Anna French · Director

Wellesley, MA Find on LinkedIn ↗
Pini Orbach · Director

Wellesley, MA Find on LinkedIn ↗
Serge Messerlian · Director

Wellesley, MA Find on LinkedIn ↗
Victoria Richon · Director

Wellesley, MA Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗